TopFunds

Abbott Laboratories

NYSE: ABT

Stock price

102.55 USD

(-19.12%) 5 years

Medical - Devices

Insider Transactions

5Y price score: (26)
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: -19.12%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
02-sep.-26Sale(27)109.5(2,958)24,549MCCOY JOHN A. JR.officer: VICE PRESIDENT AND CONTROLLERlink
25-aug.-26Sale(218,535)115.6(25,256,090)486,758Ford Robert Bdirector, officer: CHAIRMAN AND CEOlink
25-aug.-26Sale(180,297)116.2(20,948,708)306,461Ford Robert Bdirector, officer: CHAIRMAN AND CEOlink
11-aug.-26Sale(5,850)109.8(642,506)70,724Morrone Louis H.officer: EXECUTIVE VICE PRESIDENTlink
30-jun.-26Award432--14,022Stratton John Gdirectorlink
30-jun.-26Award416--6,746Roman Michael Fdirectorlink
30-jun.-26Award363--5,963Gonzalez Patricia Paoladirectorlink
30-jun.-26Award231--231Conroy Kevin Tdirectorlink
30-jun.-26Award347--450Ahuja Nitadirectorlink
07-may.-26Purchase2,00086.8173,64023,319Stratton John Gdirectorlink

81.9

52-week range

137.4

102.55

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

4.9 %

Dividend Yield TTM

2.4 %

Market cap $

$ 177,451

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

33

Price / Book TTM

3.5

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

(0.6)

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

(22) %

(11) %

183.7 %

Free cash flow per share growth

87.7 %

32.1 %

243.5 %

Earnings per share growth

(47.5) %

48.8 %

26.5 %

Dividends

Previous dividend:0.63 per share, Paid, Ex-div date Jul 15, 2026
Next dividend:0.63 per share, Declared, Ex-div date Oct 15, 2026

Analyst ratings

Price Target Low

92

Price Target High

143

Price Target Median

120.5

Buy

32

Hold

9

Sell

0

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
2.9
0.9
0.3
1.3
2.1
2.5
3.9
3.9
3.3
7.6
3.7
2.4%
3.8
4.1
4.3
4.6
4.9
5
02FCF per share
1.2
1.4
2.5
2.8
2.5
3.2
4.8
4.4
2.9
3.6
4.2
13.1%
4.1
4.4
4.7
5
5.3
5.3
03Dividends per share
Help
Adjusted for splitsLearn more
1
1
1.1
1.1
1.3
1.4
1.8
1.9
2
2.2
2.4
9.4%
-
-
-
-
-
-
04Dividends payout, %
32.6%
109.9%
387.6%
83.4%
61.6%
57%
45.3%
47.7%
62.1%
28.6%
63.1%
6.8%
-
-
-
-
-
-
05Revenue
$ 20,405
$ 20,853
$ 27,390
$ 30,578
$ 31,904
$ 34,608
$ 43,075
$ 43,653
$ 40,109
$ 41,950
$ 44,328
8.1%
$ 47,904
$ 51,769
$ 55,945
$ 60,458
$ 65,336
$ 67,296
06ㅤ% Change
-
2.2%
31.4%
11.6%
4.3%
8.5%
24.5%
1.3%
(8.1)%
4.6%
5.7%
8.1%
8.1%
8.1%
8.1%
8.1%
8.1%
8.1%
07Net Income
4,423
1,400
477
2,368
3,687
4,495
7,071
6,933
5,723
13,402
6,524
4%
6,779
7,325
7,916
8,555
9,245
9,522
08ㅤ% Margin
21.7%
6.7%
1.7%
7.7%
11.6%
13%
16.4%
15.9%
14.3%
32%
14.7%
14.2% A
14.2%
14.2%
14.2%
14.2%
14.2%
14.2%
09CFO
2,966
3,203
5,570
6,300
6,136
7,901
10,533
9,581
7,261
8,558
9,566
12.4%
9,554
10,325
11,158
12,058
13,030
13,421
10ㅤ% Of revenue
14.5%
15.4%
20.3%
20.6%
19.2%
22.8%
24.5%
22%
18.1%
20.4%
21.6%
19.9% A
19.9%
19.9%
19.9%
19.9%
19.9%
19.9%
11CAPEX
(1,110)
(1,121)
(1,135)
(1,394)
(1,638)
(2,177)
(1,885)
(1,777)
(2,202)
(2,207)
(2,171)
6.9%
(2,322)
(2,483)
(2,655)
(2,839)
(3,036)
(3,247)
12ㅤ% Change
-
1%
1.3%
22.8%
17.5%
32.9%
(13.4)%
(5.7)%
23.9%
0.2%
(1.6)%
6.9% A
6.9%
6.9%
6.9%
6.9%
6.9%
6.9%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
1,856
2,082
4,435
4,906
4,498
5,724
8,648
7,804
5,059
6,351
7,395
14.8%
7,232
7,842
8,503
9,219
9,994
10,174
14Total assets
44,001
55,011
76,250
67,173
67,887
72,548
75,196
74,438
73,214
81,414
86,713
7%
92,800
99,314
106,285
113,745
121,729
130,274
15ㅤ% Change
-
25%
38.6%
(11.9)%
1.1%
6.9%
3.7%
(1)%
(1.6)%
11.2%
6.5%
7%
7%
7%
7%
7%
7%
7%
16Total liabilities
19,921
31,949
45,152
36,451
36,586
39,545
39,172
37,533
34,387
33,513
33,942
5.5%
36,325
38,874
41,603
44,523
47,648
50,993
17ㅤ% Of assets
45.3%
58.1%
59.2%
54.3%
53.9%
54.5%
52.1%
50.4%
47%
41.2%
39.1%
39.1% A
39.1%
39.1%
39.1%
39.1%
39.1%
39.1%
18Shareholders Equity
24,080
23,062
31,098
30,722
31,301
33,003
36,024
36,905
38,827
47,901
52,771
8.2%
56,475
60,439
64,682
69,222
74,081
79,281
19Net Debt
4,000
3,386
18,517
15,722
15,239
13,052
9,452
8,064
8,977
7,659
6,545
5.1%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
1,506,000
1,483,000
1,749,000
1,770,000
1,781,000
1,786,000
1,789,000
1,764,000
1,749,000
1,748,000
1,747,000
1.5%
1,773,126
1,799,644
1,826,557
1,853,873
1,881,598
1,909,738
21ㅤ% Change
-
(1.5)%
17.9%
1.2%
0.6%
0.3%
0.2%
(1.4)%
(0.9)%
(0.1)%
(0.1)%
1.5%
1.5%
1.5%
1.5%
1.5%
1.5%
1.5%
22ROA
10.1%
2.5%
0.6%
3.5%
5.4%
6.2%
9.4%
9.3%
7.8%
16.5%
7.5%
-
7.3%
7.4%
7.5%
7.5%
7.6%
7.3%
23ROE
18.4%
6.1%
1.5%
7.7%
11.8%
13.6%
19.6%
18.8%
14.7%
28%
12.4%
-
12%
12.1%
12.2%
12.4%
12.5%
12%
24Interest coverage
16.6
10.7
2.2
5.3
5.6
7.5
22.4
26.5
9.2
11.3
23.6
-
-
-
-
-
-
-
25Dividend Yield
2.2%
2.7%
1.9%
1.6%
1.5%
1.3%
1.3%
1.7%
1.9%
2%
1.9%
-
-
-
-
-
-
-
26P/E Ratio
15
40.4
211.4
53.6
42
43.4
35.5
27.9
33.4
14.7
33.5
-
-
-
-
-
-
-
27Stock price range
39-51
36-45
39-57
56-74
66-89
63-114
106-141
95-139
90-115
100-121
111-140
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
66,137
56,573
99,507
126,984
153,569
194,126
249,814
192,462
190,870
195,872
218,882
12.7%
116,292
128,512
141,953
156,739
173,003
-
29FCF Yield
2.8%
3.7%
4.5%
3.9%
2.9%
3%
3.5%
4.1%
2.7%
3.2%
3.4%
1.9%
6.2%
6.1%
6%
5.9%
5.8%
-
30Average stock price
45.1
40.8
48.3
65.3
77.5
88.6
123.6
117.1
102.4
110.5
125.7
10.8%
65.6
71.4
77.7
84.5
91.9
-
31 CEO
RF
Robert Ford